Albrecht Stenzinger (A Stenzinger)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 52

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Genes, chromosomes & cancer

International journal of cancer

NPJ precision oncology

Journal of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Gustav, Nic Gabriel Reitsam, Zunamys Itzell Carrero, Chiara Maria Lavinia Loeffler, Marko van Treeck, Tanwei Yuan, Nicholas P West, Philip Quirke, Titus Josef Brinker, Hermann Brenner, Loëtitia Favre, Bruno Märkl, Albrecht Stenzinger, Alexander Brobeil, Michael Hoffmeister, Julien Calderaro, Anaïs Pujals, Jakob Nikolas Kather
Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology. NPJ precision oncology 8 (1) (2024)
Anders Edsjö, Hege G Russnes, Janne Lehtiö, David Tamborero, Eivind Hovig, Albrecht Stenzinger, Richard Rosenquist, null null
High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond. Journal of internal medicine (2024)
Marco Gustav, Nic Gabriel Reitsam, Zunamys Itzell Carrero, Chiara Maria Lavinia Loeffler, Marko van Treeck, Tanwei Yuan, Nicholas P West, Philip Quirke, Titus Josef Brinker, Hermann Brenner, Loëtitia Favre, Bruno Märkl, Albrecht Stenzinger, Alexander Brobeil, Michael Hoffmeister, Julien Calderaro, Anaïs Pujals, Jakob Nikolas Kather
Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology. NPJ precision oncology 8 (1) (2024)
Maria Pouyiourou, Tilmann Bochtler, Cornelia Coith, Harriett Wikman, Bianca Kraft, Thomas Hielscher, Albrecht Stenzinger, Sabine Riethdorf, Klaus Pantel, Alwin Krämer
Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary. Clinical chemistry 70 (1) (2024)
Anders Edsjö, Hege G Russnes, Janne Lehtiö, David Tamborero, Eivind Hovig, Albrecht Stenzinger, Richard Rosenquist, null null
High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond. Journal of internal medicine 295 (6) (2024)
Marco Gustav, Nic Gabriel Reitsam, Zunamys Itzell Carrero, Chiara Maria Lavinia Loeffler, Marko van Treeck, Tanwei Yuan, Nicholas P West, Philip Quirke, Titus Josef Brinker, Hermann Brenner, Loëtitia Favre, Bruno Märkl, Albrecht Stenzinger, Alexander Brobeil, Michael Hoffmeister, Julien Calderaro, Anaïs Pujals, Jakob Nikolas Kather
Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology. NPJ precision oncology 8 (1) (2024)
Maria Pouyiourou, Tilmann Bochtler, Cornelia Coith, Harriett Wikman, Bianca Kraft, Thomas Hielscher, Albrecht Stenzinger, Sabine Riethdorf, Klaus Pantel, Alwin Krämer
Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary. Clinical chemistry 70 (1) (2024)
Petros Christopoulos, Richard Schlenk, Daniel Kazdal, Miriam Blasi, Jochen Lennerz, Rajiv Shah, Jan Budczies, Nisar Malek, Stefan Fröhling, Richard Rosenquist, Peter Schirmacher, Farastuk Bozorgmehr, Jonas Kuon, Martin Reck, Michael Thomas, Albrecht Stenzinger
Real-world data for precision cancer medicine - a European perspective. Genes, chromosomes & cancer (2023)
Andreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, Christoph E Heilig, Jennifer Hüllein, Lino Möhrmann, Arne Jahn, Dorothea Hanf, Irina A Kerle, Hans Martin Singh, Barbara Hutter, Sebastian Uhrig, Martina Fröhlich, Olaf Neumann, Andreas Hartig, Sascha Brückmann, Steffen Hirsch, Kerstin Grund, Nicola Dikow, Daniel B Lipka, Marcus Renner, Irfan Ahmed Bhatti, Leonidas Apostolidis, Richard F Schlenk, Christian P Schaaf, Albrecht Stenzinger, Evelin Schröck, Daniel Hübschmann, Christoph Heining, Peter Horak, Hanno Glimm, Stefan Fröhling
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology. NPJ precision oncology 7 (1) (2023)
Maria Pouyiourou, Bianca N Kraft, Timothy Wohlfromm, Michael Stahl, Boris Kubuschok, Harald Löffler, Ulrich T Hacker, Gerdt Hübner, Lena Weiss, Michael Bitzer, Thomas Ernst, Philipp Schütt, Thomas Hielscher, Stefan Delorme, Martina Kirchner, Daniel Kazdal, Markus Ball, Klaus Kluck, Albrecht Stenzinger, Tilmann Bochtler, Alwin Krämer
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial. Nature communications 14 (1) (2023)
Bouchra Tawk, Katrin Rein, Christian Schwager, Maximilian Knoll, Ute Wirkner, Juliane Hörner-Rieber, Jakob Liermann, Ina Kurth, Panagiotis Balermpas, Claus Michael Rödel, Annett Linge, Steffen Loeck, Fabian Lohaus, Ingeborg Tinhofer, Mechthild Krause, Martin Stuschke, Anca-Ligia Grosu, Daniel Zips, Stephanie Elisabeth Combs, Claus Belka, Albrecht Stenzinger, Christel Herold-Mende, Michael Baumann, Peter Schirmacher, Juergen Debus, Amir Abdollahi
DNA-Methylome based Tumor Hypoxia Classifier Identifies HPV-negative Head & Neck Cancer Patients at Risk for Locoregional Recurrence After Primary Radiochemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Anders Edsjö, Louise Holmquist, Birgit Geoerger, Frédérique Nowak, Georgy Gomon, Catherine Alix-Panabières, Carolin Ploeger, Ulrik Lassen, Christophe Le Tourneau, Janne Lehtiö, Patrick A Ott, Andreas von Deimling, Stefan Fröhling, Emile Voest, Frederick Klauschen, Rodrigo Dienstmann, Aisha Alshibany, Lillian L Siu, Albrecht Stenzinger
Precision cancer medicine: Concepts, current practice, and future developments. Journal of internal medicine (2023)
A L Illert, Albrecht Stenzinger, Michael Bitzer, Peter Horak, V I Gaidzik, Y Möller, J Beha, Ö Öner, F Schmitt, S Laßmann, S Ossowski, C P Schaaf, M Hallek, Tim Henrik Brümmendorf, P Albers, T Fehm, P Brossart, H Glimm, Dirk Schadendorf, A Bleckmann, Christian H Brandts, I Esposito, E Mack, C Peters, C Bokemeyer, Stefan Fröhling, T Kindler, Hana Algül, V Heinemann, Hartmut Döhner, Ralf Christian Bargou, V Ellenrieder, P Hillemanns, F Lordick, A Hochhaus, M W Beckmann, T Pukrop, M Trepel, L Sundmacher, S Wesselmann, G Nettekoven, F Kohlhuber, O Heinze, Jan Budczies, M Werner, K Nikolaou, A J Beer, G Tabatabai, W Weichert, U Keilholz, M Boerries, Oliver Kohlbacher, J Duyster, Robert Thimme, T Seufferlein, P Schirmacher, N P Malek
The German Network for Personalized Medicine to enhance patient care and translational research. Nature medicine (2023)
Petros Christopoulos, Richard Schlenk, Daniel Kazdal, Miriam Blasi, Jochen Lennerz, Rajiv Shah, Jan Budczies, Nisar Malek, Stefan Fröhling, Richard Rosenquist, Peter Schirmacher, Farastuk Bozorgmehr, Jonas Kuon, Martin Reck, Michael Thomas, Albrecht Stenzinger
Real-world data for precision cancer medicine-A European perspective. Genes, chromosomes & cancer (2023)
Michael Menzel, Stephan Ossowski, Sebastian Kral, Patrick Metzger, Peter Horak, Ralf Marienfeld, Melanie Börries, Steffen Wolter, Markus Ball, Olaf Neumann, Sorin Armeanu-Ebinger, Christopher Schroeder, Uta Matysiak, Hannah Goldschmid, Vincent Schipperges, Axel Fürstberger, Michael Allgäuer, Timo Eberhardt, Jakob Niewöhner, Andreas Blaumeiser, Carolin Ploeger, Tobias Bernd Haack, Timothy Kwang Yong Tay, Olga Kelemen, Thomas Pauli, Martina Kirchner, Klaus Kluck, Alexander Ott, Marcus Renner, Jakob Admard, Axel Gschwind, Silke Lassmann, Hans Kestler, Falko Fend, Anna Lena Illert, Martin Werner, Peter Möller, Thomas Theodor Werner Seufferlein, Nisar Malek, Peter Schirmacher, Stefan Fröhling, Daniel N Kazdal, Jan Budczies, Albrecht Stenzinger
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients. NPJ precision oncology 7 (1) (2023)
Nicolas Hohmann, Martin Ronald Sprick, Azaz Ahmed, Juergen Burhenne, Marietta Kirchner, Lucian Le Cornet, Markus Kratzmann, Jacek Hajda, Albrecht Stenzinger, Karen Steindorf, Stefan Delorme, Heinz-Peter Schlemmer, Sabine Riethdorf, Ron van Schaik, Klaus Pantel, Jens Thomas Siveke, Thomas Seufferlein, Dirk Jäger, Walter Emil Haefeli, Flavia Carla Meotti, Christoph Springfeld
Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy. Clinical and translational science (2023)
Xiang Zheng, Poonam Sarode, Andreas Weigert, Kati Turkowski, Prakash Chelladurai, Stefan Günther, Carsten Kuenne, Hauke Winter, Albrecht Stenzinger, Simone Reu, Friedrich Grimminger, Thorsten Stiewe, Horst-Walter Birk, Soni Savai Pullamsetti, Soni Savai Pullamsetti
The HDAC2-SP1 axis orchestrates pro-tumor macrophage polarization. Cancer research (2023)
Albrecht Stenzinger, Ejner K Moltzen, Eva Winkler, Fruzsina Molnar-Gabor, Nisar Malek, Alexandru Costescu, Brigitte Nybo Jensen, Frédérique Nowak, Carmine Pinto, Ole Petter Ottersen, Peter Schirmacher, Jenni Nordborg, Thomas Seufferlein, Stefan Fröhling, Anders Edsjö, Jesus Garcia-Foncillas, Nicola Normanno, Bettina Lundgren, Mikaela Friedman, Natacha Bolanos, Katrina Tatton-Brown, Sue Hill, Richard Rosenquist
Implementation of precision medicine in healthcare - a European perspective. Journal of internal medicine (2023)
Marcelo Vailati Negrão, Haniel A Araujo, Giuseppe Lamberti, Alissa J Cooper, Neal S Akhave, Teng Zhou, Lukas Delasos, J Kevin Hicks, Mihaela Aldea, Gabriele Minuti, Jacobi Hines, Jacqueline V Aredo, Michael J Dennis, Turja Chakrabarti, Susan C Scott, Paolo Bironzo, Matthias Scheffler, Petros Christopoulos, Albrecht Stenzinger, Jonathan W Riess, So Yeon Kim, Sarah B Goldberg, Mingjia Li, Qi Wang, Yun Qing, Ying Ni, Minh Truong Do, Richard Lee, Biagio Ricciuti, Joao M Victor Alessi, Jing Wang, Blerina Resuli, Lorenza Landi, Shu-Chi Tseng, Mizuki Nishino, Subba R Digumarthy, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Ara A Vaporciyan, George R Blumenschein, Jianjun Zhang, Dwight H Owen, Collin M Blakely, Giannis S Mountzios, Catherine A Shu, Christine M Bestvina, Marina-Chiara Garassino, Kristen A Marrone, Jhanelle E Gray, Sandip Pravin Patel, Amy L Cummings, Heather A Wakelee, Juergen Wolf, Giorgio Vittorio Scagliotti, Federico Cappuzzo, Fabrice Barlesi, Pradnya D Patil, Leylah Drusbosky, Don L Gibbons, Funda Meric-Bernstam, Jiun-Kae Jack Lee, John Victor Heymach, David S Hong, Rebecca S Heist, Mark M Awad, Ferdinandos Skoulidis
Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC. Cancer discovery (2023)
Petros Christopoulos, Richard Schlenk, Daniel Kazdal, Miriam Blasi, Jochen Lennerz, Rajiv Shah, Jan Budczies, Nisar Malek, Stefan Fröhling, Richard Rosenquist, Peter Schirmacher, Farastuk Bozorgmehr, Jonas Kuon, Martin Reck, Michael Thomas, Albrecht Stenzinger
Real-world data for precision cancer medicine-A European perspective. Genes, chromosomes & cancer (2023)
Olaf Neumann, Markus Ball, Ulrich Lehmann, Peter Schirmacher, Albrecht Stenzinger, Daniel N Kazdal
[Genes and pathways: FGFR2 translocations and gene fusion analysis]. Pathologie (Heidelberg, Germany) 43 (5) (2022)
Tilmann Bochtler, Timothy Wohlfromm, Thomas Hielscher, Damian Stichel, Maria Pouyiourou, Bianca Kraft, Olaf Neumann, Volker Endris, Andreas von Deimling, Albrecht Stenzinger, Alwin Krämer
Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary. Genes, chromosomes & cancer 61 (9) (2022)
E Rempel, K Kluck, S Beck, Iordanis Ourailidis, Daniel N Kazdal, Olaf Neumann, A L Volckmar, M Kirchner, H Goldschmid, Nicole Pfarr, W Weichert, Daniel Hübschmann, S Fröhling, Christian Sutter, C P Schaaf, P Schirmacher, V Endris, Albrecht Stenzinger, Jan Budczies
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD). NPJ precision oncology 6 (1) (2022)
Josephine Kam Tai K Dermawan, Nooshin Dashti, Sarah Chiang, Gulisa Turashvili, Brendan C Dickson, Lora H Ellenson, Martina Kirchner, Albrecht Stenzinger, Gunhild Mechtersheimer, Abbas Agaimy, Cristina R Antonescu
Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners. Genes, chromosomes & cancer (2022)
Daniel N Kazdal, Véronique Hofman, Petros Christopoulos, Véronique Hofman, Albrecht Stenzinger, Paul Hofman
Fusion-positive non-small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications. Genes, chromosomes & cancer 61 (5) (2022)
Dana Westphal, M Garzarolli, M Sergon, Peter Horak, Barbara Hutter, J C Becker, M Wiegel, E Maczey, Sophia Freya Ulrike Blum, S Grosche-Schlee, A Rütten, Selma Ugurel, Albrecht Stenzinger, Hanno Glimm, Daniela E Aust, G Baretton, Stefan Beissert, Stefan Fröhling, Silke Redler, Harald M Surowy, Friedegund Meier
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma. The British journal of dermatology (2021)
Gunhild Mechtersheimer, Mindaugas Andrulis, Klaus-Wolfgang Delank, Anna-Lena Volckmar, Lei Zhang, Moritz von Winterfeld, Albrecht Stenzinger, Cristina R Antonescu
RREB1-MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site? Genes, chromosomes & cancer 60 (8) (2021)
Peter Horak, Jonas Leichsenring, Hannah Goldschmid, Simon Kreutzfeldt, Daniel Kazdal, Veronica Teleanu, Volker Endris, Laura Gieldon, Michael Allgäuer, Anna-Lena Volckmar, Nicola Dikow, Marcus Renner, Martina Kirchner, Roland Penzel, Carolin Ploeger, Regine Brandt, Huriye Seker-Cin, Jan Budczies, Christoph E Heilig, Olaf Neumann, Christian Patrick Schaaf, Peter Schirmacher, Stefan Fröhling, Albrecht Stenzinger
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine. Genes, chromosomes & cancer (2021)
David Gonzalez, Albrecht Stenzinger
Homologous recombination repair deficiency (HRD): From biology to clinical exploitation. Genes, chromosomes & cancer 60 (5) (2021)
Max Schmitt, Roman Christoph Maron, Achim Hekler, Albrecht Stenzinger, Axel Hauschild, Michael Weichenthal, Markus Tiemann, Dieter Krahl, Heinz Kutzner, Jochen Sven Utikal, Sebastian Haferkamp, Jakob Nikolas Kather, Frederick Klauschen, Eva Krieghoff-Henning, Stefan Fröhling, Christof von Kalle, Titus Josef Brinker
Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study. Journal of medical Internet research 23 (2) (2021)
Martina Kirchner, Julia Glade, Ulrich Lehmann, Sabine Merkelbach-Bruse, Michael Hummel, Annika Lehmann, Marcel Trautmann, Jörg Kumbrink, Andreas Jung, Wolfgang Dietmaier, Volker Endris, Daniel Kazdal, Carolin Ploeger, Matthias Evert, David Horst, Hans Kreipe, Thomas Kirchner, Eva Wardelmann, Reinhard Büttner, Wilko Weichert, Manfred Dietel, Peter Schirmacher, Albrecht Stenzinger, Nicole Pfarr
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays. Genes, chromosomes & cancer 59 (8) (2020)
Katharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, Petros Christopoulos, Moritz von Winterfeld, Esther Herpel, Benjamin Goeppert, Gunhild Mechtersheimer, Hans-Peter Sinn, Albrecht Stenzinger, Peter Schirmacher, Hauke Winter, Monika Eichinger, Arne Warth, Mark Kriegsmann
Immunohistological expression of oestrogen receptor, progesterone receptor, mammaglobin, human epidermal growth factor receptor 2 and GATA-binding protein 3 in non-small-cell lung cancer. Histopathology 77 (6) (2020)
Leonie W Wahjudi, Stephan Bernhardt, Khalid Abnaof, Peter Horak, Simon Kreutzfeldt, Christoph Heining, Simone Borgoni, Corinna Becki, Daniela Berg, Daniela Richter, Barbara Hutter, Sebastian Uhrig, Katrin Pfütze, Jonas Leichsenring, Hanno Glimm, Benedikt Brors, Christof von Kalle, Albrecht Stenzinger, Ulrike Korf, Stefan Fröhling, Stefan Wiemann
Integrating proteomics into precision oncology. International journal of cancer 148 (6) (2020)
Tilmann Bochtler, Anna Reiling, Volker Endris, Thomas Hielscher, Anna-Lena Volckmar, Olaf Neumann, Martina Kirchner, Jan Budczies, Lukas C Heukamp, Jonas Leichsenring, Michael Allgäuer, Daniel N Kazdal, Harald Löffler, Wilko Weichert, Peter Schirmacher, Albrecht Stenzinger, Alwin Krämer
Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary. International journal of cancer 146 (11) (2020)
Suranand B Talla, Eugen Rempel, Volker Endris, Maximilian Jenzer, Michael Allgäuer, Constantin Schwab, Daniel Kazdal, Fabian Stögbauer, Anna-Lena Volckmar, Ildiko Kocsmar, Olaf Neumann, Peter Schirmacher, Stefanie Zschäbitz, Stefan Duensing, Jan Budczies, Albrecht Stenzinger, Martina Kirchner
Immuno-oncology gene expression profiling of formalin-fixed and paraffin-embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing. Genes, chromosomes & cancer 59 (7) (2020)
Clemens Messerschmidt, Benedikt Obermayer, Konrad Klinghammer, Sebastian Ochsenreither, Denise Treue, Albrecht Stenzinger, Hanno Glimm, Stefan Fröhling, Thomas Kindler, Christian H Brandts, Klaus Schulze-Osthoff, Wilko Weichert, Ingeborg Tinhofer, Frederick Klauschen, Ulrich Keilholz, Dieter Beule, Damian T Rieke
Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC. International journal of cancer 147 (8) (2020)
Albrecht Stenzinger, Jeffrey D Allen, Jörg Maas, Mark D Stewart, Diana M Merino, Madison M Wempe, Manfred Dietel
Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions. Genes, chromosomes & cancer 58 (8) (2019)
Steffen Dietz, Petros Christopoulos, Lisa Gu, Anna-Lena Volckmar, Volker Endris, Zhao Yuan, Simon J Ogrodnik, Tomasz Zemojtel, Claus-Peter Heussel, Marc A Schneider, Michael Meister, Thomas Muley, Martin Reck, Matthias Schlesner, Michael Thomas, Albrecht Stenzinger, Holger Sültmann
Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer. Cold Spring Harbor molecular case studies 5 (6) (2019)
Anna-Lena Volckmar, Jonas Leichsenring, Martina Kirchner, Petros Christopoulos, Olaf Neumann, Jan Budczies, Cristiano Manuel Morais de Oliveira, Eugen Rempel, Ivo Buchhalter, Regine Brandt, Michael Allgäuer, Suranand Babu Talla, Moritz von Winterfeld, Esther Herpel, Benjamin Goeppert, Amelie Lier, Hauke Winter, Tilman Brummer, Stefan Fröhling, Martin Faehling, Jürgen R Fischer, Claus Peter Heußel, Felix Herth, Felix Lasitschka, Peter Schirmacher, Michael Thomas, Volker Endris, Roland Penzel, Albrecht Stenzinger
Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases. International journal of cancer 145 (3) (2019)
Nicole Pfarr, Martina Kirchner, Ulrich Lehmann, Jonas Leichsenring, Sabine Merkelbach-Bruse, Julia Glade, Michael Hummel, Fabian Stögbauer, Annika Lehmann, Marcel Trautmann, Jörg Kumbrink, Andreas Jung, Wolfgang Dietmaier, Volker Endris, Daniel Kazdal, Matthias Evert, David Horst, Hans Kreipe, Thomas Kirchner, Eva Wardelmann, Ulrik Lassen, Reinhard Büttner, Wilko Weichert, Manfred Dietel, Peter Schirmacher, Albrecht Stenzinger
Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays. Genes, chromosomes & cancer 59 (3) (2019)
Jonas Leichsenring, Peter Horak, Simon Kreutzfeldt, Christoph Heining, Petros Christopoulos, Anna-Lena Volckmar, Olaf Neumann, Martina Kirchner, Carolin Ploeger, Jan Budczies, Christoph E Heilig, Barbara Hutter, Martina Fröhlich, Sebastian Uhrig, Daniel N Kazdal, Michael Allgäuer, Alexander Harms, Eugen Rempel, Ulrich Lehmann, Michael Thomas, Nicole Pfarr, Ninel Azoitei, Irina Bonzheim, Ralf Marienfeld, Peter Möller, Martin Werner, Falko Fend, Melanie Boerries, Nikolas von Bubnoff, Silke Lassmann, Thomas Longerich, Michael Bitzer, Thomas Seufferlein, Nisar Malek, Wilko Weichert, Peter Schirmacher, Roland Penzel, Volker Endris, Benedikt Brors, Frederick Klauschen, Hanno Glimm, Stefan Fröhling, Albrecht Stenzinger
Variant classification in precision oncology. International journal of cancer 145 (11) (2019)
Tilmann Bochtler, Volker Endris, Jonas Leichsenring, Anna Reiling, Olaf Neumann, Anna-Lena Volckmar, Martina Kirchner, Michael Allgäuer, Peter Schirmacher, Alwin Krämer, Albrecht Stenzinger
Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome. International journal of cancer 145 (11) (2019)
Patrick Schelb, Simon A A Kohl, Jan Philipp Radtke, Manuel Wiesenfarth, Philipp Kickingereder, Sebastian Bickelhaupt, Tristan Anselm Kuder, Albrecht Stenzinger, Markus Hohenfellner, Heinz-Peter Schlemmer, Klaus H Maier-Hein, David Bonekamp
Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment. Radiology 293 (3) (2019)
Ivo Buchhalter, Eugen Rempel, Volker Endris, Michael Allgäuer, Olaf Neumann, Anna-Lena Volckmar, Martina Kirchner, Jonas Leichsenring, Amelie Lier, Moritz von Winterfeld, Roland Penzel, Petros Christopoulos, Michael Thomas, Stefan Fröhling, Peter Schirmacher, Jan Budczies, Albrecht Stenzinger
Size matters: Dissecting key parameters for panel-based tumor mutational burden analysis. International journal of cancer 144 (4) (2018)
P Christopoulos, M Kirchner, F Bozorgmehr, Volker Endris, M Elsayed, Jan Budczies, J Ristau, R Penzel, F J Herth, C P Heussel, M Eichhorn, T Muley, M Meister, J R Fischer, S Rieken, F Lasitschka, H Bischoff, R Sotillo, P Schirmacher, Michael Thomas, Albrecht Stenzinger
Identification of a highly lethal V3+ TP53+ subset in ALK+ lung adenocarcinoma. International journal of cancer 144 (1) (2018)
Steffen Dietz, Aviezer Lifshitz, Daniel N Kazdal, Alexander Harms, Volker Endris, Hauke Winter, Albrecht Stenzinger, Arne Warth, Martin Sill, Amos Tanay, Holger Sültmann
Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas. International journal of cancer 144 (5) (2018)
Denise Treue, Michael Bockmayr, Albrecht Stenzinger, Daniel Heim, Svenja Hester, Frederick Klauschen
Proteogenomic systems analysis identifies targeted therapy resistance mechanisms in EGFR-mutated lung cancer. International journal of cancer 144 (3) (2018)
Anna-Lena Volckmar, Volker Endris, Matthias M Gaida, Jonas Leichsenring, Fabian Stögbauer, Michael Allgäuer, Moritz von Winterfeld, Roland Penzel, Martina Kirchner, Regine Brandt, Olaf Neumann, Holger Sültmann, Peter Schirmacher, Jochen Rudi, Daniel Schmitz, Albrecht Stenzinger
Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study. Genes, chromosomes & cancer 58 (1) (2018)
Anna-Lena Volckmar, Holger Sültmann, Anja Riediger, Thoas Fioretos, Peter Schirmacher, Volker Endris, Albrecht Stenzinger, Steffen Dietz
A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications. Genes, chromosomes & cancer 57 (3) (2017)
Jonas Leichsenring, Anna-Lena Volckmar, Martina Kirchner, Daniel N Kazdal, Mark Kriegsmann, Fabian Stögbauer, Teresa Bockmayr, Frederick Klauschen, Felix J F Herth, Roland Penzel, Arne Warth, Peter Schirmacher, Volker Endris, Albrecht Stenzinger
Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility. Genes, chromosomes & cancer 57 (2) (2017)
Jan Budczies, Michael Bockmayr, Frederick Klauschen, Volker Endris, Stefan Fröhling, Peter Schirmacher, Carsten Denkert, Albrecht Stenzinger
Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors. Genes, chromosomes & cancer 56 (8) (2017)
Nicole Pfarr, Silvia Darb-Esfahani, Jonas Leichsenring, Eliane Taube, Melanie Boxberg, Ioana Braicu, Moritz Jesinghaus, Roland Penzel, Volker Endris, Aurelia Noske, Wilko Weichert, Peter Schirmacher, Carsten Denkert, Albrecht Stenzinger
Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology. Genes, chromosomes & cancer 56 (10) (2017)